W2O symplur

News

W2O has chalked up its fifth acquisition in less than a year with a deal to buy healthcare social media analytics company Symplur.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.